Li Xu

23PUBLICATIONS
53CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyInnate immunityPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Dec 08, 2025
HBV Reactivation in Patients with Hepatocellular Carcinoma Treated with PD-1/-L1 Antibodies and Concurrent Antiviral Prophylaxis Agents: A Prospective Observational Study.

Zefeng Du, Zhicheng Lai, Yexing Huang

|Jul 10, 2025
Hyper-Relapse Disease is a Special Pattern of Relapse of Hepatocellular Carcinoma After Curative Hepatectomy: A Retrospective Cohort Study.

Zi-Liang Yang, Yi-Xiang Gan, Jing-Xuan Xu

|Feb 04, 2025
Transarterial Chemoembolization with Radiofrequency Ablation versus Surgical Resection for Small Late-Recurrence Hepatocellular Carcinoma.

Yao-Jun Zhang, Jinbin Chen, Zhongguo Zhou

|Dec 18, 2024
Radiofrequency Ablation Versus Stereotactic Body Radiotherapy for Recurrent Small Hepatocellular Carcinoma: A Randomized, Open-Label, Controlled Trial.

Mian Xi, Zhoutian Yang, Li Hu

|Jun 26, 2024
Cholinergic macrophages promote the resolution of peritoneal inflammation.

Shufeng Luo, Huiling Lin, Chong Wu

|Mar 11, 2024
Efficacy and Safety of Conversion Surgery for Advanced Hepatocellular Carcinoma After Hepatic Arterial Infusion Chemotherapy.

Wenxuan Li, Zhikai Zheng, Jiongliang Wang

Pageof 4

Frequent Collaborators

13 joint publications

Yaojun Zhang

9 joint publications

Jinbin Chen

8 joint publications

Yangxun Pan

4 joint publications

Zhongguo Zhou